Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Octreotide acetate (0.05mg) Injection
Therapeutic Category
Endocrinology, ENDOCRINOLOGY and Hormonal range, Gastroenterology
Dosage Form
Injection
Packaging Type
Ampule
Packaging
5x1ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Octrate 0.05 Injection containing Octreotide Acetate is used for the management of hormonal and gastrointestinal disorders. It helps in controlling excessive hormone secretion and improving related clinical conditions.
Octreotide works as a somatostatin analogue that suppresses the release of various hormones and gastrointestinal secretions, supporting effective symptom control and disease management.
The injection is widely used in endocrinology, gastroenterology, and hospital critical care settings, leading to consistent demand in specialized medical treatment protocols.
With increasing requirement for advanced hormonal and gastrointestinal therapies, this product offers strong business potential for distributors and institutional suppliers. Its specialized hospital usage, steady clinical demand, and important therapeutic role make it a reliable product for consistent sales and growth in the specialty care segment.
Some patients may experience nausea, abdominal discomfort, diarrhea, constipation, headache, or injection site reactions. Rarely, gallstones, blood glucose changes, thyroid dysfunction, or allergic reactions may occur and require medical attention.
Octrate 0.05 Injection is indicated for the treatment of acromegaly, carcinoid tumors, vasoactive intestinal peptide-secreting tumors (VIPomas), and management of bleeding esophageal varices. It helps reduce hormone overproduction, control diarrhea and flushing, and stabilize endocrine-related conditions.
This injection should be used under strict medical supervision. Regular monitoring of blood glucose, thyroid function, and gallbladder health is recommended during therapy. Use cautiously in patients with diabetes or liver disorders.
Store in a refrigerator between 2°C to 8°C. Do not freeze. Protect from light and keep out of reach of children.
Composition : Omeprazole (20mg) Capsule
Composition : Domperidone (10mg) + Omeprazole (20mg) in Strip Packing of 15 Tablets
Composition : Pantoprazole (E.C.) I.P. 40mg (E.C.) + Domperidone (I.R.) I.P. 10mg + Domperidone (S.R.) I.P. 20mg Capsules
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Rabeprazole Sodium (E.C.) I.P. 20mg + Domperidone (S.R.) I.P. 20mg + Domperidone (I.R.) I.P. 10mg
Composition : Rabeprazole (20mg) + Itopride (150mg)
Composition : Lansoprazole (15mg) Tablet
Composition : Lansoprazole (30mg)
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Octrate 0.05 Injection, containing Octreotide acetate 0.05mg, has strong demand in the super-specialty hospital segment, making it a niche but valuable injectable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastroenterology, endocrinology, and critical care portfolios.
Medical distributors and agencies can benefit from the consistent hospital use of somatostatin analogs in conditions like acromegaly, carcinoid syndrome, VIPomas, and other endocrine or gastrointestinal hormone-related disorders. Octrate 0.05 Injection helps strengthen a specialized ICU and super-specialty injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Octrate 0.05 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from niche hospital demand, consistent institutional usage, reliable supply chain support, and good margins when partnering for Octrate 0.05 Injection distribution.
Medical distributors, stockists, and wholesalers interested in Octrate 0.05 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.